US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist
  • 0.647
  • -0.023-3.46%
Close Jul 29 16:00 ET
  • 0.647
  • 0.0000.00%
Post 16:51 ET
31.46MMarket Cap-604P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
818.18%1.72M
340.96%5.49M
1,105.96%1.82M
2,988.24%2.1M
5,215.38%1.38M
-81.30%187K
-91.67%1.25M
-98.17%151K
-97.16%68K
-99.05%26K
Operating revenue
818.18%1.72M
340.96%5.49M
1,105.96%1.82M
2,988.24%2.1M
5,215.38%1.38M
-81.30%187K
-91.67%1.25M
-98.17%151K
-97.16%68K
-99.05%26K
Cost of revenue
Gross profit
Operating expense
6.03%14.39M
5.00%57.48M
3.06%15.5M
21.80%13.52M
11.40%14.9M
-10.97%13.57M
-6.66%54.75M
-6.88%15.04M
-27.99%11.1M
2.55%13.37M
Selling and administrative expenses
0.24%4.19M
3.16%16.68M
24.43%4.61M
3.32%3.65M
12.35%4.25M
-19.01%4.18M
-6.57%16.17M
-20.29%3.7M
-14.47%3.53M
-11.64%3.78M
-General and administrative expense
0.24%4.19M
3.16%16.68M
24.43%4.61M
3.32%3.65M
12.35%4.25M
-19.01%4.18M
-6.57%16.17M
-20.29%3.7M
-14.47%3.53M
-11.64%3.78M
Research and development costs
8.60%10.2M
5.76%40.8M
-3.93%10.89M
30.42%9.87M
11.03%10.65M
-6.85%9.39M
-6.70%38.58M
-1.47%11.33M
-32.93%7.57M
9.47%9.59M
Operating profit
5.32%-12.67M
2.82%-51.99M
8.13%-13.68M
-3.52%-11.42M
-1.27%-13.52M
6.03%-13.38M
-22.40%-53.5M
-88.58%-14.89M
15.26%-11.03M
-29.55%-13.35M
Net non-operating interest income expense
18.45%321K
558.60%1.42M
45.26%398K
444.74%414K
381.36%332K
1,694.12%271K
368.43%215K
6,929.25%274K
204.00%76K
-591.67%-118K
Non-operating interest income
-12.32%562K
186.75%2.66M
43.20%905K
250.00%700K
540.91%564K
7,912.50%641K
1,921.87%928K
16,113.44%632K
700.00%200K
266.67%88K
Non-operating interest expense
-34.86%241K
74.61%1.25M
41.62%507K
130.65%286K
12.62%232K
1,380.00%370K
--713K
--358K
--124K
--206K
Other net income (expense)
-156.68%-157K
277K
19K
258K
Special income (charges)
----
-156.68%-157K
-926.32%-157K
--0
--0
----
--277K
--19K
--0
--258K
-Less:Impairment of capital assets
----
----
----
--0
--0
----
----
----
--0
---258K
-Gain on sale of property,plant,equipment
----
-156.68%-157K
----
----
----
----
--277K
----
----
----
Income before tax
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-21.40%-53.01M
-84.96%-14.59M
15.69%-10.96M
-28.49%-13.21M
Income tax
Net income
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
15.69%-10.96M
-28.49%-13.21M
Net income continuous Operations
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
15.69%-10.96M
-28.49%-13.21M
Minority interest income
Net income attributable to the parent company
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
15.69%-10.96M
-28.49%-13.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.81%-12.35M
4.30%-50.73M
7.94%-13.43M
-0.46%-11.01M
0.17%-13.19M
8.04%-13.11M
-20.04%-53.01M
-74.04%-14.59M
15.69%-10.96M
-28.49%-13.21M
Basic earnings per share
13.79%-0.25
25.50%-1.11
23.68%-0.29
22.58%-0.24
21.62%-0.29
34.09%-0.29
-5.67%-1.49
-52.00%-0.38
24.39%-0.31
-12.12%-0.37
Diluted earnings per share
13.79%-0.25
25.50%-1.11
23.68%-0.29
22.58%-0.24
21.62%-0.29
34.09%-0.29
-5.67%-1.49
-52.00%-0.38
24.39%-0.31
-12.12%-0.37
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 818.18%1.72M340.96%5.49M1,105.96%1.82M2,988.24%2.1M5,215.38%1.38M-81.30%187K-91.67%1.25M-98.17%151K-97.16%68K-99.05%26K
Operating revenue 818.18%1.72M340.96%5.49M1,105.96%1.82M2,988.24%2.1M5,215.38%1.38M-81.30%187K-91.67%1.25M-98.17%151K-97.16%68K-99.05%26K
Cost of revenue
Gross profit
Operating expense 6.03%14.39M5.00%57.48M3.06%15.5M21.80%13.52M11.40%14.9M-10.97%13.57M-6.66%54.75M-6.88%15.04M-27.99%11.1M2.55%13.37M
Selling and administrative expenses 0.24%4.19M3.16%16.68M24.43%4.61M3.32%3.65M12.35%4.25M-19.01%4.18M-6.57%16.17M-20.29%3.7M-14.47%3.53M-11.64%3.78M
-General and administrative expense 0.24%4.19M3.16%16.68M24.43%4.61M3.32%3.65M12.35%4.25M-19.01%4.18M-6.57%16.17M-20.29%3.7M-14.47%3.53M-11.64%3.78M
Research and development costs 8.60%10.2M5.76%40.8M-3.93%10.89M30.42%9.87M11.03%10.65M-6.85%9.39M-6.70%38.58M-1.47%11.33M-32.93%7.57M9.47%9.59M
Operating profit 5.32%-12.67M2.82%-51.99M8.13%-13.68M-3.52%-11.42M-1.27%-13.52M6.03%-13.38M-22.40%-53.5M-88.58%-14.89M15.26%-11.03M-29.55%-13.35M
Net non-operating interest income expense 18.45%321K558.60%1.42M45.26%398K444.74%414K381.36%332K1,694.12%271K368.43%215K6,929.25%274K204.00%76K-591.67%-118K
Non-operating interest income -12.32%562K186.75%2.66M43.20%905K250.00%700K540.91%564K7,912.50%641K1,921.87%928K16,113.44%632K700.00%200K266.67%88K
Non-operating interest expense -34.86%241K74.61%1.25M41.62%507K130.65%286K12.62%232K1,380.00%370K--713K--358K--124K--206K
Other net income (expense) -156.68%-157K277K19K258K
Special income (charges) -----156.68%-157K-926.32%-157K--0--0------277K--19K--0--258K
-Less:Impairment of capital assets --------------0--0--------------0---258K
-Gain on sale of property,plant,equipment -----156.68%-157K------------------277K------------
Income before tax 5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-21.40%-53.01M-84.96%-14.59M15.69%-10.96M-28.49%-13.21M
Income tax
Net income 5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M15.69%-10.96M-28.49%-13.21M
Net income continuous Operations 5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M15.69%-10.96M-28.49%-13.21M
Minority interest income
Net income attributable to the parent company 5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M15.69%-10.96M-28.49%-13.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.81%-12.35M4.30%-50.73M7.94%-13.43M-0.46%-11.01M0.17%-13.19M8.04%-13.11M-20.04%-53.01M-74.04%-14.59M15.69%-10.96M-28.49%-13.21M
Basic earnings per share 13.79%-0.2525.50%-1.1123.68%-0.2922.58%-0.2421.62%-0.2934.09%-0.29-5.67%-1.49-52.00%-0.3824.39%-0.31-12.12%-0.37
Diluted earnings per share 13.79%-0.2525.50%-1.1123.68%-0.2922.58%-0.2421.62%-0.2934.09%-0.29-5.67%-1.49-52.00%-0.3824.39%-0.31-12.12%-0.37
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg